Evidence map›Paper›PMID 36927843›Full record

ArticleJournal of medical Internet research2023

Artificial Intelligence-Based Psoriasis Severity Assessment: Real-world Study and Application.

Kai Huang, Xian Wu, Yixin Li, Chengzhi Lv, Yangtian Yan, Zhe Wu, Mi Zhang, Weihong Huang, Zixi Jiang, Kun Hu and 22 more

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Demographic Reporting and the Absence of Hispanic/Latino Representation in Dermatology Artificial Intelligence: A Scoping Review.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2026
    Article
  7. Artificial intelligence-based quantification of epidermal proliferation and apoptosis in human skin.JID innovations : skin science from molecules to population health · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 9 institutions in 2 countries.

Kai Huang *Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0003-3348-2723
Xian Wu *Tencent, Beijing, China.ORCID 0000-0003-1118-9710
Yixin LiDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0001-8740-5040
Chengzhi LvDepartment of Dermatology, Dalian Dermatosis Hospital, Liaoning, China.ORCID 0000-0002-6963-1834
Yangtian YanTencent, Beijing, China.ORCID 0000-0002-3294-9283
Zhe WuTencent, Beijing, China.ORCID 0000-0002-5371-4352
Mi ZhangDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0001-6795-0076
Weihong HuangMobile Health Ministry of Education - China Mobile Joint Laboratory, Xiangya Hospital Central South University, Changsha, Hunan, China.ORCID 0000-0002-7168-4943
Zixi JiangDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0002-1744-9782
Kun HuDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0001-9717-4012
Mingjia LiDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0002-2903-8489
Juan SuDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0001-7035-2560
Wu ZhuDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0002-3645-7059
Fangfang LiDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0002-7474-7348
Mingliang ChenDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0003-0755-6848
Jing ChenDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0001-9359-6568
Yongjian LiDepartment of Dermatology, Second Affiliated Hospital of Nanhua University, Hengyang, Hunan, China.ORCID 0000-0001-9005-2522
Mei ZengDepartment of Dermatology, Shaoyang Central Hospital, Shaoyang, Hunan, China.ORCID 0000-0003-4124-2930
Jianjian ZhuDepartment of Dermatovenerology, The First People's Hospital Of Changde City, Changde, Hunan, China.ORCID 0000-0002-0538-0343
Duling CaoDepartment of Dermatology, Xiangtan Central Hospital, Xiangtan, Hunan, China.ORCID 0000-0003-3540-581X
Xing HuangDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0002-2373-3464
Lei HuangTencent, Beijing, China.ORCID 0000-0003-4101-0697
Xing HuDepartment of Dermatology, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan, China.ORCID 0000-0002-2531-8977
Zeyu ChenState Key Laboratory of High Performance Complex Manufacturing, College of Mechanical and Electrical Engineering, Central South University, Changsha, Hunan, China.ORCID 0000-0002-7383-014X
Jian KangDepartment of Dermatology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0003-3797-256X
Lei YuanChina Mobile (Chengdu) Industrial Research Institute, Chengdu, Sichuan, China.ORCID 0000-0003-2361-071X
Chengji HuangChina Mobile (Chengdu) Industrial Research Institute, Chengdu, Sichuan, China.ORCID 0000-0002-4679-1667
Rui GuoChina Mobile (Chengdu) Industrial Research Institute, Chengdu, Sichuan, China.ORCID 0000-0002-8379-6715
Alexander NavariniDepartment of Dermatology, University Hospital of Basel, Basel, Switzerland.ORCID 0000-0001-7059-632X
Yehong KuangDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0002-1133-1791
Xiang ChenDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0001-8187-636X
Shuang ZhaoDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0001-7081-6177
Central South University · CNTencent (China) · CNChina Mobile (China) · CNDalian Dermatosis Hospital · CNHunan Normal University · CNThe Central Hospital of Shaoyang · CNThe First People's Hospital of Changde · CNUniversity Hospital of Basel · CHXiangyang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPsoriasis is one of the most frequent inflammatory skin conditions and could be treated via tele-dermatology, provided that the current lack of reliable tools for objective severity assessments is overcome. Psoriasis Area and Severity Index (PASI) has a prominent level of subjectivity and is rarely used in real practice, although it is the most widely accepted metric for measuring psoriasis severity currently.

objectiveThis study aimed to develop an image-artificial intelligence (AI)-based validated system for severity assessment with the explicit intention of facilitating long-term management of patients with psoriasis.

methodsA deep learning system was trained to estimate the PASI score by using 14,096 images from 2367 patients with psoriasis. We used 1962 patients from January 2015 to April 2021 to train the model and the other 405 patients from May 2021 to July 2021 to validate it. A multiview feature enhancement block was designed to combine vision features from different perspectives to better simulate the visual diagnostic method in clinical practice. A classification header along with a regression header was simultaneously applied to generate PASI scores, and an extra cross-teacher header after these 2 headers was designed to revise their output. The mean average error (MAE) was used as the metric to evaluate the accuracy of the predicted PASI score. By making the model minimize the MAE value, the model becomes closer to the target value. Then, the proposed model was compared with 43 experienced dermatologists. Finally, the proposed model was deployed into an app named SkinTeller on the WeChat platform.

resultsThe proposed image-AI-based PASI-estimating model outperformed the average performance of 43 experienced dermatologists with a 33.2% performance gain in the overall PASI score. The model achieved the smallest MAE of 2.05 at 3 input images by the ablation experiment. In other words, for the task of psoriasis severity assessment, the severity score predicted by our model was close to the PASI score diagnosed by experienced dermatologists. The SkinTeller app has been used 3369 times for PASI scoring in 1497 patients from 18 hospitals, and its excellent performance was confirmed by a feedback survey of 43 dermatologist users.

conclusionsAn image-AI-based psoriasis severity assessment model has been proposed to automatically calculate PASI scores in an efficient, objective, and accurate manner. The SkinTeller app may be a promising alternative for dermatologists' accurate assessment in the real world and chronic disease self-management in patients with psoriasis.

Indexed as

Artificial IntelligencePsoriasisChronic DiseaseHumansSeverity of Illness IndexSurveys and Questionnairesartificial intelligencechronic diseasedeep learning systemdermatologydesigninflammationmanagementmobile appmodelPASIpsoriasisPsoriasis Area and Severity Indexpsoriasis severity assessmenttoolsusers

Identifiers

PMID36927843
PMCPMC10131673
OpenAlexW4327575282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.